Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 20;12(1):17.
doi: 10.1186/s40635-023-00588-2.

Response Letter to: Correspondence regarding the article by Murugan et al on Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach

Raghavan Murugan  1   2 , Kianoush Kashani  3 , Paul M Palevsky  4   5   6
Affiliations

Response Letter to: Correspondence regarding the article by Murugan et al on Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach

Raghavan Murugan et al. Intensive Care Med Exp. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

RM, KK, and PMP filed an international patent application for the method of fluid removal described herein (Patent no. PCT/US2023/012204). RM received research grants from NIDDK and consulting fees from Baxter Inc., AM Pharma Inc., Bioporto Inc. and La Jolla Inc., unrelated to this study. KK received research grants NIDDK and from, Philips Research North America, and Google, a speaker honorarium from Nikkiso Critical Care Medical Supplies (Shanghai) Co., Ltd, and consulting fees to Mayo Clinic and from Baxter Inc.; PMP received consulting fees and advisory committee fees from Durect, Health-Span Dx, and Novartis; served on a Data and Safety Monitoring Board for Baxter; served as a member of an endpoint adjudication committee for GE Healthcare.

References

    1. Murugan R, Kashani K, Palevsky PM. Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach. Intensive Care Med Exp. 2023;11:83. doi: 10.1186/s40635-023-00566-8. - DOI - PMC - PubMed
    1. Levey AS, Eckardt KU, Dorman NM, Christiansen SL, Hoorn EJ, Ingelfinger JR, Inker LA, Levin A, Mehrotra R, Palevsky PM, Perazella MA, Tong A, Allison SJ, Bockenhauer D, Briggs JP, Bromberg JS, Davenport A, Feldman HI, Fouque D, Gansevoort RT, Gill JS, Greene EL, Hemmelgarn BR, Kretzler M, Lambie M, Lane PH, Laycock J, Leventhal SE, Mittelman M, Morrissey P, Ostermann M, Rees L, Ronco P, Schaefer F, St Clair Russell J, Vinck C, Walsh SB, Weiner DE, Cheung M, Jadoul M, Winkelmayer WC. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2020;97:1117–1129. doi: 10.1016/j.kint.2020.02.010. - DOI - PubMed
    1. Raina R, Bedoyan JK, Lichter-Konecki U, Jouvet P, Picca S, Mew NA, Machado MC, Chakraborty R, Vemuganti M, Grewal MK, Bunchman T, Sethi SK, Krishnappa V, McCulloch M, Alhasan K, Bagga A, Basu RK, Schaefer F, Filler G, Warady BA. Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy. Nat Rev Nephrol. 2020;16:471–482. doi: 10.1038/s41581-020-0267-8. - DOI - PMC - PubMed
    1. Neyra JA, Nadkarni GN. Continuous kidney replacement therapy of the future: innovations in information technology, data analytics, and quality assurance systems. Adv Chronic Kidney Dis. 2021;28:13–19. doi: 10.1053/j.ackd.2021.03.020. - DOI - PubMed
    1. Leypoldt JK, Pietribiasi M, Echeverri J, Harenski K. Modeling acid-base balance during continuous kidney replacement therapy. J Clin Monit Comput. 2022;36:179–189. doi: 10.1007/s10877-020-00635-3. - DOI - PubMed

LinkOut - more resources